Buscar
Mostrando documentos 1-3 de 3
Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design
Emergence of coronaviruses poses a threat to global health and economy. The current outbreak
of SARS-CoV-2 has infected more than 28,000,000 people and killed more than 915,000. To date,
there is no treatment for coronavirus ...
COVID-19 update: The race to therapeutic development
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), represents an unprecedented challenge to global public health. At the time of this review,
COVID-19 has been diagnosed in over ...
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Various human pathogenic viruses employ envelope glycoproteins for host cell receptor
recognition and binding, membrane fusion and viral entry. The spike (S) glycoprotein of
betacoronavirus SARS-CoV-2 is a homotrimeric ...